Tata Capital Healthcare Fund has acquired a minority stake in Linux Laboratories, an India-based pharmaceutical company that manufactures medicines and products for segments such as central nervous system (CNS), dermatology and nutraceutical, for INR800m-INR1b (approximately USD10.8-13.5m). Read more… Read More
True North has acquired a minority stake in Anthem Biosciences, an integrated drug discovery, development and manufacturing services provider based in India. Read more… Read More
PS Alliance, an investment unit of South Korean automotive and electronic components manufacturer Poongsung Group, led a KRW305b (approximately USD276m) investment in South Korea-based e-commerce platform Tmon. As part of the round, existing shareholders KKR and Anchor Equity Partners have invested an additional KRW50b (approximately USD45m). Read… Read More
Tiger Global Management led a USD100m Series C for Infra.Market, an India-based logistics and materials procurement platform for construction and real estate, with follow-on from Foundamental, Accel Partners, Nexus Venture Partners, Evolvence India Fund and Sistema Asia Fund, at a reported USD1b valuation. Read More
Temasek, K3 Ventures, the New Ventures arm of the Singapore Economic Development Board (EDB New Ventures), NX Food, FEBE Ventures, and Blue Horizon have invested a USD10m seed round for Next Gen, a plant-based foods company based in Singapore. Read more… Read More
Ocean Link has reached a USD580m final close for its second fund targeting investments in the travel, tourism, and consumer technology sectors in China. Read more… Read More
KKR has acquired a 38% stake in Hyundai Global Service, the aftersales marine services arm of South Korea-based shipbuilder Hyundai Heavy Industries Holdings, for USD723m. Read more… Read More
Indian renewable energy company ReNew Power has entered into an agreement to merge with Nasdaq-listed SPAC RMG Acquisition Corporation II. Upon closing, the combined entity is expected to be listed on the Nasdaq under the new ticker symbol “RNW.” The transaction is expected to close in Q2 2021. Read More
OrbiMed and Oceanpipe Capital led a USD130m Series B for China-based biopharmaceutical company Yisheng Biopharma. Read more… Read More
Thermo Fisher Scientific, Shiyu Capital, ABC International Holdings Limited, Sunland Capital, CCBI Tech Venture, and existing shareholder YF Capital have invested a USD150m Series B for China-based diagnostics company WuXi Diagnostics. Read more… Read More
(default archive template)